2021 Sweet Pharma Day Winner is HDAX Therapeutics

Montréal, Canada – (BUSINESSWIRE) October 8, 2021 – AmorChem, BioQuébec and CQDM, co-organizers of Sweet Pharma Day, are pleased to announce that HDAX Therapeutics is the winner of the 2021 edition. Sixteen Canadian startup companies (“Sweet 16”) selected by representatives from global pharma companies, made an elevator pitch in front of 150+ participants, who voted…

Accelerating the transition from idea to market – Submission of the RSRI brief

Accelerating the transition from idea to market – RSRI submits brief to public consultations on the Quebec Research and Innovation Strategy 2022. (Quebec City, May 31, 2021) – The sector-based industrial research clusters (RSRI) have submitted their proposals for stimulating innovation as part of the public consultations on the Quebec Research and Innovation Strategy 2022…

Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers

May 15th – 2020 – CQDM congratulates Theratechnologies and UQAM’s Professor Borhane Annabi for the positive results presented at the Virtual Annual Meeting II of the American Association for Cancer Research (AACR), particularly those obtained with its docetaxel-peptide conjugate TH-1902 for the treatment of triple-negative breast cancer. These are very encouraging results! To read Theratechnologies press…